These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5893914)

  • 1. [Data on infants born after treatment with methylacetoxyprogesterone (MAP) in pregnancy].
    D'Incerti Bonini L
    Ann Ostet Ginecol; 1965 Oct; 87(10):703-22. PubMed ID: 5893914
    [No Abstract]   [Full Text] [Related]  

  • 2. Dysfunctional bleeding subsequent to progestin therapy.
    Luby RJ
    Obstet Gynecol; 1965 Oct; 26(4):467-9. PubMed ID: 5294149
    [No Abstract]   [Full Text] [Related]  

  • 3. [Colpocytological aspects and therapy of dysendocrine threatened abortion, using methylacetoxyprogesterone (MAP)].
    Cubesi G
    Minerva Ginecol; 1969 Dec; 21(23):1598-611. PubMed ID: 5392869
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of hormonal treatment in threatened and habitual abortion].
    Tarlantas D; Moschovakis K
    Geburtshilfe Frauenheilkd; 1966 May; 26(5):563-4. PubMed ID: 5935246
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of gestanon therapy in women with threatened and habitual abortion].
    Despodova Ts
    Akush Ginekol (Sofiia); 1970; 9(3):208-13. PubMed ID: 5470932
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combined intensive pharmacotherapy in premature labor with habitual abortion and threatened abortion].
    Maksimov GP; Chernega MIa; Zaĭtsev LM
    Vrach Delo; 1988 Jul; (7):76-9. PubMed ID: 3188477
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences with the gestagen Turinal in treating threatened and habitual abortions (author's transl)].
    Pociatek A; Holomán I; Bzdůchová E
    Bratisl Lek Listy; 1977 Jan; 67(1):87-91. PubMed ID: 843964
    [No Abstract]   [Full Text] [Related]  

  • 8. Human chorionic gonadotrophin in the treatment of threatened and recurrent abortion. A preliminary reappraisal.
    Utian WH
    S Afr Med J; 1974 Apr; 48(18):769-71. PubMed ID: 4825878
    [No Abstract]   [Full Text] [Related]  

  • 9. [Attempted gestanone therapy of imminent and habitual abortions].
    Zymek-Giermańska T; Sward J
    Wiad Lek; 1965 Sep; 18(18):1447-50. PubMed ID: 5840901
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of threatened and habitual abortions with Turinal preparations].
    Szucka-May H; Sternadel Z
    Ginekol Pol; 1975 Dec; 46(12):1265-9. PubMed ID: 1205224
    [No Abstract]   [Full Text] [Related]  

  • 11. [Human chorionic gonadotropin (HCG) excretion in the urine in habitual threatened abortion treated with gestanon].
    Wawryk R; Samochowiec E; Rzempoluch J; Pilarz E
    Ginekol Pol; 1973 Jun; 44(6):665-70. PubMed ID: 4720463
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences in the therapy of spontaneous and habitual abortions with the oral administration of Gestanon A].
    Berić B; Suvaković D
    Med Pregl; 1971; 24(11):505-7. PubMed ID: 5140029
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of threatened and habitual abortion with human chorionic gonadotrophin. The role of serum human placental lactogen determination.
    Vorster CZ; Pannall PR; Slabber CF
    S Afr Med J; 1977 Feb; 51(6):165-6. PubMed ID: 841444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex hormones in pregnancy.
    Darling MR; Hawkins DF
    Clin Obstet Gynaecol; 1981 Aug; 8(2):405-19. PubMed ID: 7028351
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical observation on 41 cases of threatened and habitual abortion treated by blood activation and stasis removal.
    Jiang J; Li G; Zang M
    J Tradit Chin Med; 1997 Dec; 17(4):259-65. PubMed ID: 10437207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of habitual abortion with caprovestrol].
    Kovtumova LG; Turbina ZV; Rymashevskaia EP; Zelenkova LT
    Vopr Okhr Materin Det; 1976 May; 21(5):72-5. PubMed ID: 1027289
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progesterone and abortion].
    Hashiguchi S
    Sanfujinka No Jissai; 1969 Dec; 18(13):1140-6. PubMed ID: 5395804
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of acetomepegrenol in the therapy of threatened abortion].
    Sidel'nikova VM; Demidova EM; Borisova IuF; Dondukova TM; Absava GI; Korkhov VV
    Akush Ginekol (Mosk); 1990 Sep; (9):37-40. PubMed ID: 2278305
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progesterone in large doses: metabolic and therapeutic aspects].
    Montanino G; Vizzone A
    Minerva Ginecol; 1966 Aug; 18(16):880-4. PubMed ID: 5989252
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical trial and cytological assessment of enol LUTEOVIS IN THE TREATMENT OF THREATENED AND RECURRENT ABORTION.
    Burton ER; Wachtel EG
    J Obstet Gynaecol Br Commonw; 1967 Aug; 74(4):533-6. PubMed ID: 5340429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.